Oculis Holding AG
OCS
Oculis Holding AG is a clinical-stage biopharmaceutical company focused on developing treatments for ophthalmic, neuro-ophthalmic, and neurological diseases. Its current pipeline centers on OCS-01, a topical retinal candidate for diabetic macular edema; OCS-02, a topical biologic candidate for dry eye disease; and OCS-05, a neuroprotective candidate being studied for conditions such as acute optic neuritis and other disorders affecting vision and the nervous system. The company’s work is aimed at addressing unmet medical needs in eye care through formulations designed for local delivery and patient convenience. Oculis Holding AG operates as a global life sciences business with activities in Switzerland and other international markets, serving the broader biotechnology sector through research, clinical development, and disease-specific therapeutic innovation.
Valuation & Multiples
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
CHF 0.00
Net Income (TTM)
-CHF 79M
▼ -15.4% YoY
Op. Margin
–
ROIC
-47.28%
▲ +21.2pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-CHF 66M
▼ -41.8% YoY
Op. Cash Flow (TTM)
-CHF 66M
▼ -39.6% YoY
Net Debt
-CHF 211M
Net Cash Position
Cash & Equiv.
CHF 213M
Continue Research
Peers
Biotechnology · Pick stocks to compare with OCS
Held by ETFs
OCS is in 4 US ETFs. The largest of them, with OCS's weight in each:
Oculis Holding (OCS) in three numbers
Questions about Oculis Holding
Is Oculis Holding a high-quality business?
Oculis Holding scores 10 out of 100 on Intrinsiqq's quality score, which makes it a lower-quality business on these measures. The score blends 4 checks computed from company filings. Its best check is net debt at -$211M, and its weakest is return on capital at -47.3%. The Quality tab shows every check against its target.
Does Oculis Holding (OCS) pay a dividend?
No. Oculis Holding (OCS) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.
Source: company filings. Price: last close 20 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.
Spot a number that looks wrong?
Download this analysis as a PDF (Pro)
Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing OCS
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.